|
Randomized Controlled Trial
Citations 71-80 of 86 total displayed.
|
Past content
(since Nov 1998):
|
- Corrections
Error in Figure
-
Arch Neurol 2002; 59: 1975.
[Full text]
[PDF]
- Original Contributions
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
- Clifford W. Shults; David Oakes; Karl Kieburtz; M. Flint Beal; Richard Haas; Sandy Plumb; Jorge L. Juncos; John Nutt; Ira Shoulson; Julie Carter; Katie Kompoliti; Joel S Perlmutter; Stephen Reich; Matthew Stern; Ray L. Watts; Roger Kurlan; Eric Molho; Madaline Harrison; Mark Lew; and the Parkinson Study Group
Arch Neurol 2002; 59: 1541-1550.
[Abstract]
[Full text]
[PDF]
- Editorials
Experimental Neurotherapeutics: Leaps and Bounds
- Ira Shoulson
Arch Neurol 2002; 59: 689-691.
[Extract]
[Full text]
[PDF]
- Editorials
Reporting Clinical Trials: Full Access to All of the Data
- Roger N. Rosenberg; Michael Aminoff; François Boller; Per Soelberg Soerensen; Robert C. Griggs; Vladimir Hachinski; Mark Hallett; Richard T. Johnson; Christopher Kennard; Anthony E. Lang; Andrew J. Lees; Robert Lisak; John Newsom-Davis; Timothy A. Pedley; Michael E. Selzer; Douglas Zochodne
Arch Neurol 2002; 59: 27-28.
[Extract]
[Full text]
[PDF]
- Original Contributions
Evaluation of Dyskinesias in a Pilot, Randomized, Placebo-Controlled Trial of Remacemide in Advanced Parkinson Disease
- Parkinson Study Group
Arch Neurol 2001; 58: 1660-1668.
[Abstract]
[Full text]
[PDF]
- Original Contributions
A Randomized, Double-blind, Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
- Richard B. Dewey Jr; J. Thomas Hutton; Peter A. LeWitt; Stewart A. Factor
Arch Neurol 2001; 58: 1385-1392.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Double-blind Crossover Trial of Trimethoprim-Sulfamethoxazole in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
- Thorsten Schulte; Rebekka Mattern; Klaus Berger; Sandra Szymanski; Peter Klotz; Peter H. Kraus; Horst Przuntek; Ludger Schöls
Arch Neurol 2001; 58: 1451-1457.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Mild Guillain-Barré Syndrome
- Deborah M. Green; Allan H. Ropper
Arch Neurol 2001; 58: 1098-1101.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Oral Almotriptan vs Oral Sumatriptan in the Abortive Treatment of Migraine: A Double-blind, Randomized, Parallel-Group, Optimum-Dose Comparison
- Egilius L. H. Spierings; Baltazar Gomez-Mancilla; Daniel E. Grosz; Clayton R. Rowland; Fredrick S. Whaley; Kathleen J. Jirgens
Arch Neurol 2001; 58: 944-950.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease Progression
- Martin R. Farlow; Ann Hake; John Messina; Richard Hartman; Jeffrey Veach; Ravi Anand
Arch Neurol 2001; 58: 417-422.
[Abstract]
[Full text]
[PDF]
|
|